Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|October 27, 2020
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide studyJean-Baptiste Bossard, Jean-Baptiste Beuscart, Marie Robin, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Blood Advances|February 26, 2025
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in FranceCamille Bigenwald, Damien Roos-Weil, Arnaud Pagès, et al.
Haematologica|January 19, 2019
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosisMarie Robin, Sylvie Chevret, Linda Koster, et al.
Bone Marrow Transplantation|September 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TCMaxime Jullien, Eolia Brissot, Etienne Daguindau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 2, 2019
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell TransplantationNico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, et al.
Hemasphere|September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM studyCorentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.
Blood|January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphomaReid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.
Bone Marrow Transplantation|January 14, 2018
Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Xavier Poiré, Anne-Claire Gac, et al.
American Journal of Hematology|May 6, 2025
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)Yves Chalandon, Raynier Devillier, Ariane Boumendil, et al.
Pageof 6